Physician profile
Arun Solanki
NPI 1821331000
$7,157.67
in general payments reported to CMS, 2019-2025
46 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 77% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $1,199 · 2021: $1,669 · 2022: $895 · 2023: $1,075 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389 · Travel and Lodging: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.33 |
| Travel and Lodging | $1,380.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,729.30 | 2021-2025 | Skyclarys |
| Ucb, INC. | $586.44 | 2019-2023 | Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $524.45 | 2020-2023 | |
| Ipsen Biopharmaceuticals, INC | $418.24 | 2019-2022 | |
| Sk Life Science, INC. | $391.91 | 2020-2023 | |
| Supernus Pharmaceuticals, INC. | $365.27 | 2021-2023 | Qelbree |
| Sunovion Pharmaceuticals INC. | $262.42 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $218.79 | 2019-2023 | Soliris |
| Amgen INC. | $216.68 | 2019-2020 | |
| Emd Serono, INC. | $174.32 | 2020-2021 | |
| Tris Pharma INC | $163.63 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $158.64 | 2019-2023 | Jornay Pm |
| Allergan, INC. | $129.73 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $122.14 | 2020-2023 | Rytary |
| Aquestive Therapeutics, INC. | $100.38 | 2020-2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Solanki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.